| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 326,270 | 366,240 | 370,438 | 385,193 | | Cost of Revenue | 152,662 | 165,744 | 173,212 | 176,601 | | | Gross Profit | 173,608 | 200,496 | 197,226 | 208,592 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 110,865 | 161,735 | 148,923 | 157,993 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 10,710 | 10,778 | 10,858 | 13,172 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 52,033 | 27,983 | 37,445 | 37,427 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 121 | 107 | 120 | 192 | | Earnings Before Interest And Taxes | 52,154 | 28,090 | 37,565 | 37,619 | | Interest Expense | 4,911 | 5,353 | 5,434 | 5,106 | | Income Before Tax | 47,243 | 22,737 | 32,131 | 32,513 | | Income Tax Expense | 17,078 | 10,194 | 13,494 | 13,505 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 30,165 | 12,543 | 18,637 | 19,008 | | | Non-recurring Events | | Discontinued Operations | (4,737) |
-
|
-
| 151 | | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 25,428 | 12,543 | 18,637 | 19,159 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $25,428 | $12,543 | $18,637 | $19,159 |
|
0.45% Nasdaq 
0.20%
Income Statement
